Delivery Order SPE2DB22D2211-SPE2DB25FSGDF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $66,709.27, was competitively awarded with no set-aside designation and is scheduled for completion by August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $36.7K with a firm fixed price structure and an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $46,472.02 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by April 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at approximately $75,900 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, issued on June 20, 2025, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $14,017.54 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in units of 30 tablets. This is a firm fixed price contract with an ultimate completion date of September 17, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This competitively awarded, firm fixed-price delivery order has a ceiling value of $17,461.55 and an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $13,297.03 to AmerisourceBergen Drug Corp for supply of Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $16,491.43 and an ultimate completion date of September 29, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSGDFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $165,000 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. This prime contract vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal medical contracts demonstrates its established capability to meet competitive federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $165.0k | 9/26/25 |